Arcturus Therapeutics Holdings Inc. - Common Stock (ARCT)

CUSIP: 03969T109

Q2 2024 13F Holders as of 30 Jun 2024

Type / Class
Equity / Common Stock
Shares outstanding
28,423,877
Total 13F shares
26,274,363
Share change
-887,628
Total reported value
$639,738,709
Put/Call ratio
48%
Price per share
$24.35
Number of holders
169
Value change
-$34,874,203
Number of buys
76
Number of sells
104

Security key

03969T109

Report period

Q2 2024

Institutions

169

Top holders

10

Top shareholders of ARCT - Arcturus Therapeutics Holdings Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
FEDERATED HERMES, INC.
13F
Company
17%
4,695,372
$158,562,712 31 Mar 2024
13F
BlackRock Finance, Inc.
13F
Company
9.7%
2,743,002
$92,631,178 31 Mar 2024
13F
STATE STREET CORP
13F
Company
6.9%
1,959,936
$66,187,039 31 Mar 2024
13F
ARK Investment Management LLC
13F
Company
5.9%
1,689,649
$57,059,450 31 Mar 2024
13F
VANGUARD GROUP INC
13F
Company
4.9%
1,387,894
$46,869,181 31 Mar 2024
13F
Sumitomo Mitsui Trust Group, Inc.
13F
Company
4.5%
1,276,519
$43,108,047 31 Mar 2024
13F
Amova Asset Management Americas, Inc.
13F
Company
4.5%
1,276,519
$42,980,395 31 Mar 2024
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
3.9%
1,103,820
$37,276,003 31 Mar 2024
13F
Woodline Partners LP
13F
Company
3.2%
914,364
$30,878,072 31 Mar 2024
13F
MORGAN STANLEY
13F
Company
3.1%
868,447
$29,327,455 31 Mar 2024
13F
FMR LLC
13F
Company
2.2%
621,858
$21,000,145 31 Mar 2024
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
1.9%
550,263
$18,585,087 31 Mar 2024
13F
ADAGE CAPITAL PARTNERS GP, L.L.C.
13F
Company
1.6%
450,000
$15,196,500 31 Mar 2024
13F
GOLDMAN SACHS GROUP INC
13F
Company
1.3%
363,370
$12,271,005 31 Mar 2024
13F
JUPITER ASSET MANAGEMENT LTD
13F
Company
1.3%
362,344
$12,236,357 31 Mar 2024
13F
Schonfeld Strategic Advisors LLC
13F
Company
1.2%
346,494
$11,701,101 31 Mar 2024
13F
Granahan Investment Management, LLC
13F
Company
1.2%
336,147
$11,351,684 31 Mar 2024
13F
Point72 Asset Management, L.P.
13F
Company
1.2%
335,378
$11,325,715 31 Mar 2024
13F
JPMORGAN CHASE & CO
13F
Company
1.1%
317,551
$10,723,697 31 Mar 2024
13F
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
1%
285,115
$9,628,334 31 Mar 2024
13F
Portolan Capital Management, LLC
13F
Company
0.86%
244,659
$8,262,134 31 Mar 2024
13F
NORTHERN TRUST CORP
13F
Company
0.83%
236,942
$8,001,531 31 Mar 2024
13F
AMERICAN CENTURY COMPANIES INC
13F
Company
0.82%
231,745
$7,826,029 31 Mar 2024
13F
GREAT LAKES ADVISORS, LLC
13F
Company
0.74%
210,391
$7,104,904 31 Mar 2024
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.7%
198,557
$6,705,270 31 Mar 2024
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.67%
190,766
$6,442,168 31 Mar 2024
13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
13F
Company
0.63%
180,398
$6,092,040 31 Mar 2024
13F
CITADEL ADVISORS LLC
13F
Company
0.59%
167,094
$5,642,764 31 Mar 2024
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.56%
158,519
$5,353,187 31 Mar 2024
13F
Rafferty Asset Management, LLC
13F
Company
0.55%
156,593
$5,288,146 31 Mar 2024
13F
Tri Locum Partners LP
13F
Company
0.49%
138,927
$4,691,565 31 Mar 2024
13F
CITIGROUP INC
13F
Company
0.48%
136,407
$4,606,464 31 Mar 2024
13F
ROYCE & ASSOCIATES LP
13F
Company
0.46%
131,718
$4,448,117 31 Mar 2024
13F
Nuveen Asset Management, LLC
13F
Company
0.44%
123,865
$4,182,920 31 Mar 2024
13F
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP
13F
Company
0.41%
116,797
$3,944,000 31 Mar 2024
13F
Connor, Clark & Lunn Investment Management Ltd.
13F
Company
0.41%
115,945
$3,915,463 31 Mar 2024
13F
Bank of New York Mellon Corp
13F
Company
0.41%
115,603
$3,903,914 31 Mar 2024
13F
UBS Group AG
13F
Company
0.38%
107,939
$3,645,101 31 Mar 2024
13F
JACOBS LEVY EQUITY MANAGEMENT, INC
13F
Company
0.34%
95,924
$3,239,353 31 Mar 2024
13F
MARSHALL WACE, LLP
13F
Company
0.3%
84,267
$2,845,697 31 Mar 2024
13F
Neuberger Berman Group LLC
13F
Company
0.29%
82,546
$2,787,579 31 Mar 2024
13F
AQR CAPITAL MANAGEMENT LLC
13F
Company
0.26%
74,225
$2,506,578 31 Mar 2024
13F
WELLS FARGO & COMPANY/MN
13F
Company
0.25%
71,658
$2,419,891 31 Mar 2024
13F
FRANKLIN RESOURCES INC
13F
Company
0.25%
70,646
$2,385,716 31 Mar 2024
13F
OMERS ADMINISTRATION Corp
13F
Company
0.22%
63,000
$2,127,510 31 Mar 2024
13F
Man Group plc
13F
Company
0.22%
62,589
$2,113,631 31 Mar 2024
13F
NORDEA INVESTMENT MANAGEMENT AB
13F
Company
0.2%
56,931
$1,846,272 31 Mar 2024
13F
STATE OF WISCONSIN INVESTMENT BOARD
13F
Company
0.2%
56,612
$1,911,787 31 Mar 2024
13F
Assenagon Asset Management S.A.
13F
Company
0.19%
55,237
$1,865,353 31 Mar 2024
13F
Quantedge Capital Pte Ltd
13F
Company
0.18%
50,100
$1,691,877 31 Mar 2024
13F

Institutional Holders of Arcturus Therapeutics Holdings Inc. - Common Stock (ARCT) as of Q2 2024

As of 30 Jun 2024, Arcturus Therapeutics Holdings Inc. - Common Stock (ARCT) was held by 169 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 26,274,363 shares. The largest 10 holders included FEDERATED HERMES, INC., BlackRock Inc., ARK Investment Management LLC, Nikko Asset Management Americas, Inc., Sumitomo Mitsui Trust Holdings, Inc., STATE STREET CORP, VANGUARD GROUP INC, DIMENSIONAL FUND ADVISORS LP, MORGAN STANLEY, and Woodline Partners LP. This page lists 169 institutional shareholders reporting positions in this security for the Q2 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2024 vs Q1 2024 Across Filers

Q1 2024 holders
176
Q2 2024 holders
169
Holder diff
-7
Investor Q1 2024 Shares Q2 2024 Shares Share Diff Share Chg % Q1 2024 Value $ Q2 2024 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .